The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that as the sheath was inserted interaction with the previously deployed supera stent resulted in the reported device damaged by another device and thus resulting in the reported migration.The treatment appears to be related to the operational context of the procedure as a non- abbott stent was used to embed the migrated supera stent in place.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2022, the supera self expanding stent was implanted in the common femoral artery.On (b)(6) 2022 an angiography was performed and the sheath that was inserted interacted with the supera stent, causing it to migrate upward and now, no portion of the supera remains in the target lesion.A non- abbott stent was used to embed the supera in place so it will not migrate again.No additional information was provided.
|